PURPOSE: We determined the time lag between loss of retinal ganglion cell function and retinal nerve fiber layer (RNFL) thickness. METHODS: Glaucoma suspects were followed for at least four years. Patients underwent pattern electroretinography (PERG), optical coherence tomography (OCT) of the RNFL, and standard automated perimetry testing at 6-month intervals. Comparisons were made between changes in all testing modalities. To compare PERG and OCT measurements on a normalized scale, we calculated the dynamic range of PERG amplitude and RNFL thickness. The time lag between function and structure was defined as the difference in time-to-criterion loss between PERG amplitude and RNFL thickness. RESULTS: For PERG (P < 0.001) and RNFL (P = 0.030), there was a statistically significant difference between the slopes corresponding to the lowest baseline PERG amplitude stratum (≤50%) and the reference stratum (>90%). Post hoc comparisons demonstrated highly significant differences between RNFL thicknesses of eyes in the stratum with most severely affected PERG (≤50%) and the two strata with least affected PERG (>70%). Estimates suggested that the PERG amplitude takes 1.9 to 2.5 years to lose 10% of its initial amplitude, whereas the RNFL thickness takes 9.9 to 10.4 years to lose 10% of its initial thickness. Thus, the time lag between PERG amplitude and RNFL thickness to lose 10% of their initial values is on the order of 8 years. CONCLUSIONS: In patients who are glaucoma suspects, PERG signal anticipates an equivalent loss of OCT signal by several years.
PURPOSE: We determined the time lag between loss of retinal ganglion cell function and retinal nerve fiber layer (RNFL) thickness. METHODS:Glaucoma suspects were followed for at least four years. Patients underwent pattern electroretinography (PERG), optical coherence tomography (OCT) of the RNFL, and standard automated perimetry testing at 6-month intervals. Comparisons were made between changes in all testing modalities. To compare PERG and OCT measurements on a normalized scale, we calculated the dynamic range of PERG amplitude and RNFL thickness. The time lag between function and structure was defined as the difference in time-to-criterion loss between PERG amplitude and RNFL thickness. RESULTS: For PERG (P < 0.001) and RNFL (P = 0.030), there was a statistically significant difference between the slopes corresponding to the lowest baseline PERG amplitude stratum (≤50%) and the reference stratum (>90%). Post hoc comparisons demonstrated highly significant differences between RNFL thicknesses of eyes in the stratum with most severely affected PERG (≤50%) and the two strata with least affected PERG (>70%). Estimates suggested that the PERG amplitude takes 1.9 to 2.5 years to lose 10% of its initial amplitude, whereas the RNFL thickness takes 9.9 to 10.4 years to lose 10% of its initial thickness. Thus, the time lag between PERG amplitude and RNFL thickness to lose 10% of their initial values is on the order of 8 years. CONCLUSIONS: In patients who are glaucoma suspects, PERG signal anticipates an equivalent loss of OCT signal by several years.
Authors: Lori M Ventura; Nancy Sorokac; Roosevelt De Los Santos; William J Feuer; Vittorio Porciatti Journal: Invest Ophthalmol Vis Sci Date: 2006-09 Impact factor: 4.799
Authors: Lori M Ventura; Vittorio Porciatti; Kyoko Ishida; William J Feuer; Richard K Parrish Journal: Ophthalmology Date: 2005-01 Impact factor: 12.079
Authors: Vittorio Porciatti; William J Feuer; Pedro Monsalve; Giacinto Triolo; Luis Vazquez; John McSoley; Lori M Ventura Journal: J Glaucoma Date: 2017-05 Impact factor: 2.503
Authors: Arthur F Resende; Carina T Sanvicente; Hamoon Eshraghi; Alberto Garcia; Kassandra Pickel; Qiang Zhang; Michael Waisbourd; L Jay Katz Journal: Doc Ophthalmol Date: 2019-07-16 Impact factor: 2.379
Authors: Xunda Luo; Nimesh B Patel; Lakshmi P Rajagopalan; Ronald S Harwerth; Laura J Frishman Journal: Invest Ophthalmol Vis Sci Date: 2014-06-26 Impact factor: 4.799
Authors: Jean-Claude Mwanza; Hanna Y Kim; Donald L Budenz; Joshua L Warren; Michael Margolis; Scott D Lawrence; Pooja D Jani; Garrett S Thompson; Richard K Lee Journal: Invest Ophthalmol Vis Sci Date: 2015-10 Impact factor: 4.799
Authors: Phillip S Gordon; Maja Kostic; Pedro F Monsalve; Giacinto Triolo; Luri Golubev; Gabriel Luna; Lori M Ventura; William J Feuer; Vittorio Porciatti Journal: Doc Ophthalmol Date: 2020-03-09 Impact factor: 2.379